TGD001 Treatment in Thrombotic Microangiopathies
NCT07459114
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombotic Microangiopathies
ITP Immune-Mediated Thrombocytopenia
Interventions
DRUG:
TGD001
Sponsor
TargED Biopharmaceuticals B.V.